Cor pulmonale: Difference between revisions

(Text replacement - "Category:Cards" to "Category:Cardiology")
 
(12 intermediate revisions by 5 users not shown)
Line 5: Line 5:
==Clinical Features==
==Clinical Features==
===Pathophysiology===
===Pathophysiology===
*Pulmonary vasoconstriction (hypoxia, acidemia)
*Pulmonary vasoconstriction ([[hypoxia]], [[acidosis|acidemia]])
*Destruction of pulmonary vasculature by emphysema, ILD
*Destruction of pulmonary vasculature by emphysema, [[interstitial lung disease]]
*Increased blood viscosity ([[sickle cell disease]], polycythemia)
*Increased blood viscosity ([[sickle cell disease]], [[polycythemia]])
===Chronic===
===Chronic===
*[[RVH]]
*[[RVH]]
Line 26: Line 26:
**[[Acute Valve Dysfunction]]
**[[Acute Valve Dysfunction]]
**[[Aortic Dissection]]
**[[Aortic Dissection]]
**[[Dysrhthymia]]
**[[Dysrhythmia]]
**[[Endocarditis]]
**[[Endocarditis]]
**[[Hypertensive Emergency]]
**[[Hypertensive Emergency]]
Line 33: Line 33:
**[[COPD]]
**[[COPD]]
**[[PE]]
**[[PE]]
**[[PNA]]
**[[pneumonia]]
*Other
*Other
**Pure volume overload
**Pure [[fluid overload|volume overload]]
***[[Renal Failure]]
***[[Renal Failure]]
***Post-[[Transfusion]]
***Post-[[Transfusion]]
**[[Sepsis]]
**[[Sepsis]]


==Diagnosis==
==Evaluation==
===Blood tests===
===Blood tests===
*CBC (polycythemia)
*CBC ([[polycythemia]])
*ABG (oxygenation, acid-base status)
*[[ABG]] (oxygenation, acid-base status)
*alpha-1-antitrypsin
*α-1-antitrypsin
*ANA
*ANA
*Coagulation studies (protein C/S, factor V Leiden etc)
*Coagulation studies (protein C/S, factor V Leiden etc)
===CXR===
===[[CXR]]===
*Enlarged pulmonary arteries
*Enlarged pulmonary arteries
*Cardiomegaly
*Cardiomegaly
*Decreased retrosternal air space
*Decreased retrosternal air space
===EKG===
===[[ECG]]===
*[[RVH]]
*[[RVH]]
*Right axis deviation
*Right axis deviation
*[[Right bundle branch block]]
*[[Right bundle branch block]]
*R:S ratio > 1 in V1
*R:S ratio > 1 in V1
*TWI in V1-3 in acute right heart strain (as opposed to upright t-waves in posterior MI)
*S1 Q3 T3 in acute right heart strain
*Large P wave in II, III, aVF
*Large P wave in II, III, aVF
*Arrhythmia (PAC, SVT, MFAT, A-fib, A-flutter)
*[[Arrhythmia]] ([[PAC]], [[SVT]], MFAT, [[A-fib]], A-[[flutter]])


===Echo===
===[[Echocardiography]]===
*Increased RV thickness
*Increased RV thickness
*RV dilation
*RV dilation
Line 70: Line 72:
==Management==
==Management==
*Treat underlying disease
*Treat underlying disease
*Fluids, vasoconstrictors to support BP in acute setting
*Fluids, [[vasopressors|vasoconstrictors]] to support BP in acute setting
*Oxygen therapy: decreases pulmonary vasoconstriction
*[[Oxygen therapy]]: decreases pulmonary vasoconstriction
*Diuretics: decrease RV filling volume
*[[Diuretics]]: decrease RV filling volume
*[[Calcium channel blockers]]: vasodilate the pulmonary arteries
*[[Calcium channel blockers]]: vasodilate the pulmonary arteries
*Beta agonists (epoprostenol, iloprost): bronchodilate
*Beta agonists ([[epoprostenol]], iloprost): bronchodilate
*Phlebotomy for severe hypoxia leading to polycythemia
*Phlebotomy for severe hypoxia leading to polycythemia
*Lung transplant or heart-lung transplant as last resort
*Lung transplant or heart-lung transplant as last resort
Line 82: Line 84:


==See Also==
==See Also==
 
*[[Pulmonary Embolism]]
*[[COPD]]


==External Links==
==External Links==


==References==
==References==
<references/>
<references/>


[[Category:Pulm]][[Category:Cardiology]]
[[Category:Pulmonary]][[Category:Cardiology]]

Latest revision as of 00:51, 28 September 2023

Background

Clinical Features

Pathophysiology

Chronic

Acute

  • RV dilation

Signs and Symptoms

Differential Diagnosis

Evaluation

Blood tests

  • CBC (polycythemia)
  • ABG (oxygenation, acid-base status)
  • α-1-antitrypsin
  • ANA
  • Coagulation studies (protein C/S, factor V Leiden etc)

CXR

  • Enlarged pulmonary arteries
  • Cardiomegaly
  • Decreased retrosternal air space

ECG

Echocardiography

  • Increased RV thickness
  • RV dilation
  • Tricuspid insufficiency
  • High estimated PA pressures
  • Septal bowing into LV

CTPA for PE

V/Q scan for PE

Management

  • Treat underlying disease
  • Fluids, vasoconstrictors to support BP in acute setting
  • Oxygen therapy: decreases pulmonary vasoconstriction
  • Diuretics: decrease RV filling volume
  • Calcium channel blockers: vasodilate the pulmonary arteries
  • Beta agonists (epoprostenol, iloprost): bronchodilate
  • Phlebotomy for severe hypoxia leading to polycythemia
  • Lung transplant or heart-lung transplant as last resort

Disposition

See Also

External Links

References